United States · FDA National Drug Code directory

Levothyroxine sodium

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 16729-448_415fc774-31a5-124f-e063-6294a90a0e46
Product NDC: 16729-448
Form: TABLET
Composition / generic term: Levothyroxine Sodium
Labeler: Accord Healthcare Inc.
Marketing category: ANDA
Marketing start / end (source format): 20201125
Source listing expiry: 20261231

Source-listed ingredients

LEVOTHYROXINE SODIUM — 50 ug/1

These values do not establish equivalence or a dose recommendation.

Packages

90 TABLET in 1 BOTTLE (16729-448-15) · 16729-448-15
1000 TABLET in 1 BOTTLE (16729-448-17) · 16729-448-17

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →